<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: <z:chebi fb="0" ids="16865">gamma-Aminobutyric acid</z:chebi> receptor (<z:chebi fb="3" ids="16865">GABA</z:chebi>(A)r) subunit beta3-deficient mice model <z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman syndrome</z:e> by displaying impaired learning, <z:hpo ids='HP_0002353'>abnormal EEG</z:hpo> with interictal spikes and slowing, <z:hpo ids='HP_0001336'>myoclonus</z:hpo>, and <z:mp ids='MP_0000947'>convulsions</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>The beta3-subunit deficiency causes a failure of intrathalamic reticular nucleus inhibition, leading to abnormally synchronized thalamocortical oscillations </plain></SENT>
<SENT sid="2" pm="."><plain>We postulated that this pathophysiology underlies the abnormal cortical EEG and triggers interictal spikes and <z:hpo ids='HP_0001250'>seizures</z:hpo>, but extrathalamic regions also contribute to interictal spikes and <z:hpo ids='HP_0001250'>seizures</z:hpo>, so that the EEG slowing should reveal an absence-like response profile, whereas spikes and <z:hpo ids='HP_0001250'>seizures</z:hpo> have dual responsiveness to absence and partial-<z:hpo ids='HP_0001250'>seizure</z:hpo> drugs </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Recording electrodes were implanted over the parietal cortices of <z:mp ids='MP_0002169'>wild-type</z:mp>, heterozygotes, and homozygous null mice </plain></SENT>
<SENT sid="4" pm="."><plain>In each experiment, EEG was recorded for 45 min, either drug or vehicle administered, and EEG recorded for another 3 h </plain></SENT>
<SENT sid="5" pm="."><plain>Each EEG was scored for slow-wave activity, interictal spikes, and <z:hpo ids='HP_0001250'>seizures</z:hpo> by a reader blinded to treatments </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Interictal spiking and percentage of time in EEG slowing in heterozygotes were increased by the proabsence drug <z:chebi fb="0" ids="2972">baclofen</z:chebi> (<z:chebi fb="3" ids="16865">GABA</z:chebi>(B)-receptor <z:chebi fb="4" ids="48705">agonist</z:chebi>), whereas CGP 35348 (<z:chebi fb="3" ids="16865">GABA</z:chebi>(B)-receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi>) had the opposite effect </plain></SENT>
<SENT sid="7" pm="."><plain>The antiabsence drug ethosuximide markedly suppressed EEG slowing and interictal spiking in heterozygote and null mice </plain></SENT>
<SENT sid="8" pm="."><plain>Broad-spectrum clonazepam and valproate were more effective on interictal spiking than on EEG slowing, and fosphenytoin suppressed only interictal spiking </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: The results suggest that this model of <z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman syndrome</z:e>, although not expressing <z:hpo ids='HP_0011147'>typical absence seizures</z:hpo>, is characterized by hypersynchronous thalamocortical oscillations that possess absence-like pharmacologic responsiveness and promote EEG slowing, interictal spikes, and <z:mp ids='MP_0000947'>convulsive</z:mp> <z:hpo ids='HP_0001250'>seizures</z:hpo> </plain></SENT>
</text></document>